Related Experiment Video

Updated: Aug 12, 2026

A Thin-skull Window Technique for Chronic Two-photon In vivo Imaging of Murine Microglia in Models of Neuroinflammation
12:07

A Thin-skull Window Technique for Chronic Two-photon In vivo Imaging of Murine Microglia in Models of Neuroinflammation

Published on: September 19, 2010

[Cryptococcal meningoencephalitis in HIV infected immigrants. Diagnostic and therapeutic aspects with reference to

B M Weltermann1, H R Röttgers, P Lüdemann

  • 1Klinik und Poliklinik für Neurologie, Westfälische Wilhelms-Universität Münster.

Der Nervenarzt
|September 14, 1999
PubMed

Insights

Cryptococcal meningitis, a common complication in AIDS patients, requires prompt antifungal treatment. Lifelong secondary prevention with fluconazole improves outcomes, though rare resistant strains pose challenges.

Area of Science:

  • Infectious Diseases
  • Neurology
  • Immunology

Background:

  • Cryptococcal meningitis is a frequent meningoencephalitis in Human Immunodeficiency Virus (HIV) / Acquired Immunodeficiency Syndrome (AIDS) patients.
  • Before triazole antibiotics, incidence was 5-10%, declining with newer treatments like fluconazole.
  • Nonspecific meningeal signs dominate; focal neurological deficits are uncommon.

Observation:

  • Diagnosis relies on cryptococcal antigen detection in cerebrospinal fluid (CSF), India-ink microscopy, and cultures.
  • High-dose antimycotic therapy, including amphotericin B, fluconazole, and flucytosine, is crucial for prognosis.
  • Lifelong secondary prophylaxis with fluconazole is now standard practice.

Findings:

  • Recent advancements focus on improving antimycotic therapies.
  • Fluconazole-resistant and amphotericin B-resistant *Cryptococcus* strains are rare but challenging.
  • Long-term patient outcomes depend heavily on managing the underlying immunosuppression.

Implications:

  • Combining secondary prophylaxis with modern antiviral therapies is vital for managing AIDS patients with cryptococcal meningitis.
  • Evidence-based medicine and clinical decision analysis aid in managing suspected cases.
  • Continued research into novel antimycotic strategies is necessary to combat resistant fungal infections.

More Related Videos

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients13:50

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients

Published on: June 11, 2011

Identification of EcoHIV-Infected Cells in Microglia-Manipulated Transgenic Mice07:23

Identification of EcoHIV-Infected Cells in Microglia-Manipulated Transgenic Mice

Published on: December 20, 2024

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Toxoplasmosis01:28

Toxoplasmosis

Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...